Skip to content

Efficacy and Safety of Dictyophora indusiata Fisch, Psilocybe cubensis (Earle) Sing. and Sesame oil compare with 0.1% Triamcinolone lotion in treating Psoriasis Patients: Open label , Randomized controlled trial.

Efficacy and Safety of Dictyophora indusiata Fisch, Psilocybe cubensis (Earle) Sing. and Sesame oil compare with 0.1% Triamcinolone lotion in treating Psoriasis Patients: Open label , Randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180125004
Enrollment
30
Registered
2018-01-25
Start date
2018-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis&#44

Interventions

2) Secondary medicine are 0.1% Triamcinolone lotion Randomized to receive trial drug with lesion that were distributed ,1) Primary medicine are Third medicine on Wat Pho’s inscriptions consists of
Psilocybe cubensis (Earle) Sing.and Sesame oil.
Experimental Drug,Experimental Drug
Psoriasis patient,Psoriasis patient

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Psoriasis patient aged over 18 years, Lesion were distributed equally on both side of body They were signing the consent forms.

Exclusion criteria

Exclusion criteria: severe psoriasis ,Patients who are participating other ongoing project and required to continue study medication, Pregnant or in lactation or planning to become pregnant. , No allergy to herb medicine

Design outcomes

Primary

MeasureTime frame
efficacy and safety week 4,8,12 Modified Psoriasis Area and Severity Index (Modified PASI) and Physician global assessment (PGA)

Secondary

MeasureTime frame
Satisfaction study week 12 Dermatology Life Quality Index (DLQI) and Visual Analog Scale (VAS)

Countries

Thailand

Contacts

Public ContactJittima Dhitavat

Mahidol University

jittima_pu@yahoo.com087 592 1777

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026